Abstract

Miracle fruit (Synsepalum dulcificum) has been well known and studied for its unique taste-modifying ability. In this study, the monosaccharide composition, molecular weight (Mw), and in vitro bioactivities (antioxidant, -glucosidase inhibition) of polysaccharides from the seeds (MFP-S) and leaves (MFP-L) of miracle fruit were investigated. The results showed that MFP-S was a homogeneous polysaccharide (Mw 2804 Da) with glucose. MFP-L displayed three fractions (92093, 1496, and 237 Da) consisting of rhamnose, arabinose, galactose, glucose, and xylose. Moreover, the antioxidant and -glucosidase inhibition of MFP-L were significantly greater than those of MFP-S. The -glucosidase inhibition of MFP-L was remarkably better than the positive control, acarbose (an antidiabetes drug). More specifically, the 50% inhibitory concentration (IC50) values of -glucosidase activities for MFP-S, MFP-L, and acarbose were 33, 0.01, and 1 mg mL−1, separately. Therefore, MFP-L can be developed as a functional factor with both antioxidant and antidiabetes activities in food applications.

1. Introduction

The miracle fruit (Synsepalum dulcificum) is an ever green indigenous to tropical west Africa. The shrub yields ripe red berries called “miracle fruit” that exhibit an interesting and remarkable taste-modifying property of altering sour flavours to sweet [1]. The pioneering study on miracle fruit was proposed by Inglett et al. [2] whilst looking for a natural sweetener to replace saccharin and cyclamate. Kurihara and Beidler [3] first reported in Science that the active ingredient could be a special glycoprotein with a molecular weight of 44 kDa, and Brouwer et al. [4] named the glycoprotein “miraculin” in Nature. Miraculin was further extracted, and its genes have been transferred to Aspergillus oryzae, lettuce, and tomato [57] to promote the mass production of this unique glycoprotein. In addition to miracle fruit’s well-known taste-modifying ability, the fruit could be used to improve food palatability for patients who are undergoing chemotherapy [8].

It is noteworthy that all parts of this plant have medicinal importance [9]. However, Swamy et al. [10] found that few studies had been done on the medical or clinical effects of miracle fruit aside from well-established studies on the sweetening effects [11]. Inglett and Chen [12] investigated the antioxidant properties of phenolics and flavonoids in the skin, pulp, and seeds of miracle fruit and suggested it as a good source of antioxidants for functional food applications. He et al. [13] studied the total phenolic content and DPPH radical scavenging activities of extracts from the skin, pulp, and seed of miracle fruit. Du et al. [14] researched the phenolic and flavonoid content and antioxidant activity of miracle fruit flesh and seed methanol extracts, which could be used as an antioxidant-rich fruit to promote human health. Cheng et al. [15] also verified that polyphenols in seed extracts of miracle fruit were powerful antioxidants. Wang et al. [16] studied the antioxidant and antityrosinase effects of constituents of the stems of miracle fruit, suggesting the potential applications in food supplementation and medical cosmetology. Chen et al. [17] reported the inhibitory effects of aqueous extracts of miracle fruit leaves on oxidative and mutation damage and attributed them partially to its active phenolic components. Shi et al. [18] found that a butanol extract of miracle fruit exhibited equal effects to allopurinol, which is a commonly prescribed medication for gout and hyperuricemia. Therefore, they suggested that the butanol extract of miracle fruit could be used as a novel antihyperuricemia agent or health food. Moreover, Kaki Bale et al. [19] noted in a “Conference in Natural Medicine” that miracle fruit has been extensively used as an antidiabetes herbal medicine to protect the health of the Terengganu people in Malaysia, but the mechanism of effect has not been clarified. Chen et al. [20] suggested that miracle fruit could markedly raise insulin sensitivity in fructose-rich chow-fed rats, indicating that miracle fruit may be served as an adjuvant therapy for diabetic patients with insulin resistance.

Based on these very limited reports on the functional properties of polyphenol-enriched extracts from different parts of the miracle fruit plant, it was unexpected that polysaccharides have not yet been studied. However, it has been well reviewed that polysaccharides (such as tea polysaccharides) exhibit various bioactivities, including antioxidant, antidiabetes, anticancer, and immunological activities. Animal and clinical studies have suggested that tea polysaccharides play an important role in overall human health [21, 22]. Many studies have been done to search for safe and efficient antioxidants and -glucosidase inhibitors from natural materials. Their purposes were to explore bioactive additives for functional foods or therapeutic compounds to prevent the development of diabetes and slow its progression. Nonstarch polysaccharides are also a type of dietary fiber, which can improve glycaemia and insulin sensitivity, lower good pressure, and drum cholesterol levels of individuals.

Therefore, we attempted to isolate polysaccharides from the seeds and leaves of miracle fruit. Their physicochemical properties (monosaccharide composition, molecular weight) and bioactivities, including antioxidant and -glucosidase inhibitory activities in vitro, were investigated in this study.

2. Materials and Methods

2.1. Materials and Chemicals

The fresh seeds and leaves of miracle fruit were provided by the Shenzhen Miracle Fruit Co. Ltd. (Shenzhen, Guangdong, China). 2,2-Diphenyl-1-picrylhydrazyl (DPPH), 2,2′-azino-bis (3-ethylbenzothiazoline-6-sulfonic acid) (ABTS), Ferrozine, -glucosidase, and dextran molecular weight standards were purchased from Sigma Chemical Co. (St. Louis, USA). -Nitrophenyl -D-glucopyranoside (NPG) and acarbose were purchased from J&K Chemical Ltd. (Shanghai, China). All other chemicals and solvents were purchased from Sinopharm Chemical Reagent Co. Ltd. (Shanghai, China) and were of analytical grade or purer.

2.2. Extraction and Isolation of Miracle Fruit Polysaccharides

Polysaccharides are generally prepared with hot aqueous extraction followed by ethanol precipitation. The isolation processes of miracle fruit polysaccharides (MFPs) are presented in Figure 1. Both fresh seeds and leaves of miracle fruit were freeze-dried for 48 h in a Christ Alpha 1–4 LSC lyophiliser (Marin Christ, Osterode, Germany), were pulverised, passed through a 40-mesh sieve (0.43 mm), and were stored at −18°C in vacuum packaging. Each 60 g of the dried powder of seeds and leaves from miracle fruit was first processed ultrasonically with 5 volumes of 80% ethanol two times, in order to extract polyphenols, flavonoids, and oil. The dried residues were extracted with hot ultrapure water at 100°C at a ratio of 1 : 10 (w/v) for 5 h. Because the seeds contain a large amount of starch, which causes gelatinisation, -amylase was used to liquefy and decrease the viscosity of the extraction suspension at 70°C.

After extraction, the supernatant solutions were collected by centrifugation (6000; 10 min; 25°C) and concentrated to about 100 mL at 50°C using a R-215 rotary evaporator (Buchi, Zurich, Switzerland). Sevag reagent (chloroform: n-butyl alcohol = 4 : 1, v/v) was added and shaken to remove the proteins in concentrated solutions at a ratio of 1 : 5 (v/v) for three times. The concentrated liquid extracts were mixed with 4 volumes of anhydrous ethanol at 4°C overnight for precipitation of MFPs. The resultant precipitates were collected by centrifugation (6000; 15 min; 4°C). Polysaccharide precipitates were redissolved in water and precipitated with anhydrous ethanol and acetone twice again to remove other active compounds, soluble monosaccharide, and reducing sugars. At last, the polysaccharide precipitates were volatilised solvents and lyophilised to obtain the prepurified MFP fractions—those from seeds (MFP-S) and those from leaves (MFP-L).

2.3. Analysis of MFPs Monosaccharide Composition

The polysaccharide content of MFPs was determined by the phenol-sulfuric acid method using glucose as a standard [23]. The monosaccharide composition of MFPs was estimated by high-performance liquid chromatography (HPLC) after acid hydrolysis according to the method described by Wang et al. [24]. Briefly, each MFP sample (10 mg) was hydrolysed with trifluoroacetic acid (TFA, 2 M, 3 mL) at 121°C for 2 h in a sealed tube. Residual TFA was removed with a QGC-12T nitrogen blowing instrument (Quandao Co. Ltd., Shanghai, China) at 50°C. The hydrolysed samples were redissolved in ultrapure water and analysed with ICS 5000 ion chromatography (Dionex, Sunnyvale, CA) with a CarboPac PA20 analytic column (150 mm × 3 mm inner diameter) and a pulsed amperometric detector. The mobile phase consisted of 250 mM NaOH (2%) and water (98%) at a flow rate of 0.5 mL min−1.

2.4. Determination of MFPs Molecular Weight

The molecular weight (Mw) of MFPs was determined by high-performance gel-filtration chromatography (HPGFC), according to the method of Li et al. [25]. A Waters 1525 HPLC system was equipped with an Ultrahydrogel™ Linear 300 mm × 7.8 mm inner diameter × 2 (Waters Corp., Milford, MA), a Waters 2414 Refractive Index Detector (RI), and an Empower3 workstation. NaNO3 (0.1 M) was used as a mobile phase with a flow rate of 0.9 mL min−1. Dextran molecular weight standards ranging from 2.7 to 135 kDa were used for calibration and calculation of the Mw of each peak.

2.5. Antioxidant Activities

In each of the following five different assays of antioxidant activities, the concentrations of MFP-S and MFP-L samples and the positive control of ascorbic acid (Vc) or ethylenediaminetetraacetic acid (EDTA) were set to be the same: MFP-S: 0.625, 1.25, 2.5, 5, 10, 20, 40, and 80 mg mL−1; MFP-L: 0.00625, 0.0125, 0.025, 0.05, 0.1, 0.2, 0.4, and 0.8 mg mL−1; Vc/EDTA: 0.005, 0.01, 0.02, 0.04, 0.06, 0.08, 0.10, and 0.12 mg mL−1.

2.5.1. DPPH Radical Scavenging Activity

The DPPH free radical scavenging activity of the MFPs was conducted according to a slightly modified method described by Li et al. [26]. In brief, 2 mL of the MFP samples at various concentrations was mixed with 4 mL of 0.2 mM DPPH dissolved in 95% ethanol. The mixtures were shaken adequately and incubated for 20 min at 25°C in the dark. The absorbance was measured at 517 nm against a blank group. Ascorbic acid (Vc) was used as a positive control. The DPPH scavenging activity was calculated as follows: where is defined as the absorbance of the sample (sample + DPPH methanol solution), is the absorbance of the reagent blank (sample without DPPH methanol solution), and is the absorbance of the control (DPPH methanol solution without sample).

2.5.2. ABTS Radical Scavenging Activity

The ABTS radical scavenging activity of the MFPs was examined according to the method of Siddhuraju and Becker [27] with slight modification. The ABTS radical cation stock solution was prepared by mixing 88 μL of 140 mM potassium persulphate and 5 mL of 7 mM ABTS and incubating for 24 h at 25°C in the dark. The ABTS radical stock solution was then diluted with ultrapure water to obtain an absorbance of at 734 nm. MFP samples (0.4 mL) at various concentrations were excessively mixed with 6 mL of ABTS radical cation solution. The mixtures were left to stand for 1 h at 25°C in the dark, and the absorbance was tested at 734 nm. Ascorbic acid was also used as a positive control. The ABTS scavenging activity was calculated as follows: where is defined as the absorbance of the sample, is the absorbance of the reagent blank (sample without ABTS), and is the absorbance of the control (ABTS without sample).

2.5.3. Hydroxyl Radical Scavenging Activity

The hydroxyl radical scavenging activity of the MFPs was investigated according to a modified method proposed by Li et al. [26]. MFP samples (3 mL) at various concentrations were mixed with 0.5 mL FeSO4 (6 mM) and 0.5 mL H2O2 (6 mM), incubated for 10 min, and added to 0.5 mL salicylic acid (6 mM). The absorbance was measured at 510 nm after being left to stand for 30 min at 25°C. Ascorbic acid was also used as a positive control. The hydroxyl radical scavenging activity was calculated as follows:where is defined as the absorbance of the sample, is the absorbance of the reagent blank (sample without reagents), and is the absorbance of the control (reagents without sample).

2.5.4. Ferrous Ion Chelating (FIC) Activity

The chelating effect of the MFPs on Fe2+ was monitored by measuring the formation of a ferrous iron-Ferrozine complex according to the method of Chew et al. [28] with minor modification. MFP samples (4 mL) at various concentrations were mixed with 150 μL FeCl2 (1 mM), incubated for 5 min, and added to 0.6 mL Ferrozine (1 mM). The absorbance was measured at 562 nm after being left to stand for 10 min at 25°C. EDTA was used as the positive control. The ferrous ion chelating ability was calculated with the following equation:where is defined as the absorbance of the sample, is the absorbance of the reagent blank (sample without reagents), and is the absorbance of the control (reagents without sample).

2.5.5. Ferric-Reducing Antioxidant Power

The ferric-reducing antioxidant power (FRAP) assay was performed following a modified method of Wang et al. [24]. MFP samples (0.5 mL) at various concentrations were mixed with 2 mL phosphate-buffered saline solution (PBS; 0.2 M, pH 6.6) and 1 mL potassium ferricyanide (1%, w/v), separately, incubated in a 50°C water bath for 20 min and cooled immediately. After 2.5 mL trichloroacetic acid (10%, w/v) was added, the reaction mixture was centrifuged (5000; 10 min; 25°C) and 1 mL of the supernatant was mixed with 2 mL ultrapure water and 0.5 mL FeCl3 (0.1%, w/v). The absorbance was measured at 700 nm after being left to stand for 10 min at 25°C. Ascorbic acid was also used as a positive control. The higher absorbance indicated better reducing power.

2.6. α-Glucosidase Inhibition Assay

The -glucosidase inhibitory activity of the MFPs was determined according to Xu et al. [29] with slight modification. A series of polysaccharide samples at various concentrations was prepared: 10, 20, 40, 80, 160, 320, and 640 mg mL−1 for MFP-S and 0.0025, 0.005, 0.01, 0.02, 0.04, and 0.08 mg mL−1 for MFP-L. MFP samples (0.6 mL) were mixed with 0.4 mL PBS (0.1 M, pH 6.9) containing -glucosidase (0.1 U mL−1) and incubated in a 37°C water bath for 10 min. Afterward, 170 μL of 1 mM -nitrophenyl -D-glucopyranoside (NPG) as a substrate in PBS (0.1 M, pH 6.9) was added to the mixture. The reaction solution was incubated at 37°C for 30 min, and the reaction was stopped by adding 2 mL of 0.5 M Na2CO3. The -glucosidase inhibitory activity was determined by monitoring the absorbance of p-nitrophenol release from NPG at 405 nm. Acarbose (0.02, 0.2, 2, 4, 8, and 16 mg mL−1) was used as the positive control. -Glucosidase inhibitory activity was calculated with the following equation:where is defined as the absorbance of the sample, is the absorbance of the reagent blank (sample + PBS instead of other reagents), and is the absorbance of the control (PBS instead of sample).

2.7. Statistical Analysis

All experiments were performed at least twice each with triplicate sample analysis. The results are expressed as means ± SD. The method of analysis was based on the general linear model. Significant differences (set at ) between means were distinguished by least significant difference procedures using Statistix software 9.0 (Analytical Software, Tallahassee, FL, USA).

3. Results and Discussion

3.1. Monosaccharide Compositions of MFP-S and MFP-L

The yield of the polysaccharides MFP-S and MFP-L was 15.5% and 1.0%, respectively. An HPLC chromatogram of mixed standard monosaccharides is presented in Figure 2(a). From left to right peaks 1–10 were amino glucose, rhamnose, arabinose, galactosamine, galactose, glucose, xylose, mannose, fructose, and ribose, respectively. The results indicate that MFP-S and MFP-L were both heteropolysaccharides. MFP-S consisted of arabinose, galactose, and glucose in a ratio of 0.16 : 0.09 : 27.35 (Figure 2(b)). In contrast, MFP-L was composed of five monosaccharides, rhamnose, arabinose, galactose, glucose, and xylose, with ratios of 0.12 : 1.05 : 1.17 : 1.21 : 0.15 (Figure 2(c)). Actually, the differences in MFP-S and MFP-L on their monosaccharides could be predicted during the isolation process. That is, MFP-S exhibited high viscosity like glucose syrup, whilst MFP-L had a low viscosity.

3.2. Molecular Weight Distributions of MFP-S and MFP-L

The homogeneity and molecular weight (Mw) distributions of MFP-S and MFP-L were analysed by HPGFC. The average Mw of each elution peak was calculated according to the calibration curve derived from molecular weight standards. As shown in Figure 3(a), MFP-S presented a single, sharp, and symmetrical peak with an approximate Mw of 2804 Da (Mp: 683 Da), implying that MFP-S was a homogeneous polysaccharide. This result is consistent with its almost single monosaccharide composition with glucose (Figure 2(b)). Li et al. [25] reported a similar HPGFC profile for polysaccharide. MFP-L consisted of three major fractions with Mw of 92093, 1496, and 237 Da (Mp: 54038, 1267, and 200 Da) in proportion of 34%, 62%, and 4%, respectively (Figure 3(b)). The average Mw of three fractions in MFP-L was calculated to be 32249 Da.

3.3. Antioxidant Activities of MFP-S and MFP-L

The antioxidant activities of MFP-S and MFP-L with positive control were simultaneously estimated using five different methods, including DPPH, ABTS, hydroxyl radical scavenging activity, ferrous chelating ability, and ferric-reducing antioxidant power.

3.3.1. DPPH Radical Scavenging Activity

Because DPPH radicals are very stable but can be easily scavenged by antioxidants, they have been used to evaluate the free radical scavenging activity of natural compounds. As shown in Figure 4(a), all MFP-S, MFP-L, and positive control (Vc) scavenged DPPH radicals in a concentration-dependent manner at their own appropriate concentration ranges. Remarkably, MFP-L presented much greater scavenging activity than MFP-S. Calculations were done to identify concentrations that caused 50% inhibition (IC50) of antioxidant activities. More specifically, the IC50 values of DPPH for MFP-S, MFP-L, and Vc were 5.3, 0.06, and 0.019 mg mL−1, separately. Therefore, MFP-L could possibly act as a strong DPPH radical scavenger in the food application.

3.3.2. ABTS Radical Scavenging Activity

The ABTS radical scavenging activities of MFP-S, MFP-L, and Vc were determined, and the results are shown in Figure 4(b). Similar to the results of DPPH (Figure 4(a)), the ABTS radical scavenging activities of MFP-S, MFP-L, and Vc were also increased in a concentration-dependent manner. MFP-L was found to be a more effective ABTS radical scavenger than MFP-S. For example, the IC50 values of ABTS for MFP-S, MFP-L, and Vc were 5.0, 0.084, and 0.023 mg mL−1, separately. It was implied that MFP-L could be used as a natural antioxidant to scavenge ABTS free radicals. This result also confirmed the positive correlation between ABTS and DPPH radical assays about antioxidant activity [30].

3.3.3. Hydroxyl Radical Scavenging Activity

Hydroxyl radicals are well known as some of the most reactive free radicals, which can induce severe damage to the organism [31]. Therefore, scavenging activities on the hydroxyl radical generated in a Fenton reaction of MFP-S, MFP-L, and Vc were investigated in this study. It could be seen that MFP-L still exhibited significantly better hydroxyl radical scavenging activity than MFP-S, as shown in Figure 4(c). In detail, the IC50 values of hydroxyl radical for MFP-S, MFP-L, and Vc were 3.5, 0.18, and 0.055 mg mL−1, separately.

3.3.4. Ferrous Ion Chelating (FIC) Activity

The metal chelating ability was recognised as a correlative activity to antioxidant. As presented in Figure 4(d), at each considered concentration range, the FIC activities of MFP-S, MFP-L, and EDTA increased as the polysaccharide concentration increased. MFP-L also displayed a distinct advantage over MFP-S on FIC activity, whilst the overall FIC activity was not as strong as that of EDTA. Specifically, the IC50 values of FIC activity for MFP-S, MFP-L, and EDTA were 1.9, 0.083, and 0.008 mg mL−1, separately.

3.3.5. Ferric-Reducing Antioxidant Power (FRAP)

FRAP was expressed as absorbance (ABS) at 700 nm, and a higher absorbance value indicated stronger reducing power. The results of FRAP assay are shown in Figure 4(e). As expected, Vc possessed the best FRAP, followed by MFP-L and MFP-S. MFP-L still markedly exhibited much stronger activity for FRAP than MFP-S. The ABS of MFP-L at 0.00625 mg mL−1 was 0.060, which was already comparable to the ABS of MFP-S at initial 0.625 mg mL−1. At the last point of MFP-L at 0.8 mg mL−1, the right ABS was 0.652, whilst MFP-S was more than 40 mg mL−1, and Vc was less than 0.12 mg mL−1.

3.4. α-Glucosidase Inhibitory Activity

Diabetes is characterised as a high concentration of blood sugar that can cause serious complications, such as damage to the eyes, kidneys, and cardiovascular and nervous systems. -Glucosidase is an important carbohydrate digestion enzyme that has been considered as a therapeutic approach to adjust postprandial hyperglycaemia [29]. Many studies have focused on seeking effective and safe -glucosidase inhibitors from natural products to develop functional foods to combat diabetes [3236].

The dose-dependent effects on -glucosidase inhibitory activities of MFP-S, MFP-L and the positive control acarbose are displayed in Figure 5. It was amazing to note that MFP-L presented remarkably greater -glucosidase inhibitory activity than MFP-S and greater even than acarbose. More specifically, the inhibitory ability of MFP-L rose from 5.6% to 98.5% when the concentration was increased from 0.0025 to 0.08 mg mL−1. More specifically, the IC50 values of -glucosidase activities for MFP-S, MFP-L, and acarbose were 33, 0.01, and 1 mg mL−1, separately. This finding indicates that MFP-L could have a promising inhibitory effect on -glucosidase, even superior to that of the antidiabetes drug acarbose. Interestingly, it is coincident that the blood sugar values of some people with hyperglycaemia can be decreased to some extent by drinking tea made from the leaves of miracle fruit (data not shown).

Similarly, according to Xu et al. [29], the polysaccharide isolated from pu-erh tea stored for 5 years inhibits -glucosidase three times better than that from acarbose. Chen et al. [32] considered that the diversities in antioxidant and -glucosidase inhibitory activities amongst the three polysaccharides from green, oolong, and black tea appeared to be related to differences in their respective monosaccharide compositions and molecular weight distributions. They found that the high proportion of low molecular weight fractions in black tea polysaccharide contributed to its greater bioactivities of antioxidant and -glucosidase inhibition than those in green and oolong tea. According to the results of molecular weight distribution analysis of MFP-S and MFP-L (Figure 3), two fractions (Mw 1496 and 237 Da, resp.) of MFP-L accounted for 66%, whilst the single fraction of MFP-S had a higher average Mw of 2804 Da. It seems to be reasonable that low molecular weight fractions of MFP-L react easily with free radicals and other substrates to display wonderful bioactivity.

4. Conclusions

Overall, MFP-S and MFP-L have considerable differences in physicochemical properties (monosaccharide composition and molecular weight) and antioxidant and -glucosidase inhibitory activities in vitro. The results demonstrate that MFP-S was a homogeneous polysaccharide that consisted almost entirely of glucose. However, MFP-L was a heterogeneous polysaccharide with three elution fractions, which were made up of five monosaccharides: rhamnose, arabinose, galactose, glucose, and xylose. MFP-L exhibited much better antioxidant abilities than MFP-S, although they were still weaker than those of the positive control (Vc/EDTA). The most exciting feature was that MFP-L showed notable inhibition of -glucosidase, which was much better than that of the antidiabetes drug acarbose. It is suggested that MFP-L can be explored as a novel antidiabetes additive with both antioxidant and hypoglycemic bioactivities. The relationship between the structure of purified fractions from MFP-L and their bioactivities should be considered in further studies.

Conflicts of Interest

The authors declare that they have no conflicts of interest regarding the publication of this paper.

Acknowledgments

This research work was financially supported by the authors’ home institution funds.